Mutoral I

Mutoral® I is the Mutian protocol supply for feline chronic gingivostomatitis (FCGS), a severe and painful oral inflammatory condition. Cats with FCGS or stomatitis develop mouth ulcers, reddened and swollen gums, periodontal overgrowth, pain, and heavy salivation; eating becomes difficult, so appetite and day-to-day activity often fall away. Mutoral® I is intended to address this cluster of oral symptoms directly.

Mutoral® I (50 mg) is the starting phase of the two-phase oral FCGS protocol. It is given first, at a higher daily frequency, to bring the oral inflammation under control. In the source research, cats showing some improvement within 1–2 weeks of starting Mutoral® I may be switched to Mutoral® II (100 mg) for once-daily maintenance; if no improvement is seen within 2 weeks, the attending veterinarian should re-assess the diagnosis and adjust the approach. A full course usually requires about 12 weeks of continuous administration, with the overall duration guided by the severity and site of the condition and the cat's clinical and laboratory results. In the source research, administration was not affected by food.

Mutoral® I is supplied as 50 mg tablets, 14 tablets per box, for use in cats only. Commonly used dosage in the observational FCGS protocol: half a tablet per 1 kg of body weight, twice daily. The exact daily amount is weight-based and should be set and adjusted by the attending veterinarian.

Mutoral® I should not be used in cats with an allergy to any of its ingredients. It is not recommended for cats with septic infection or sepsis, or with skin and soft-tissue damage such as abscesses, cellulitis, or dermatitis. Steroids, cyclosporine A, and other immunosuppressants are not recommended during administration. Consult your veterinarian for help in the diagnosis, treatment, and control of FCGS.

Technical details: manufactured under GMP-certified conditions by Mutian Life Sciences. In the source protocol the tablets are used alongside the Mutoral oral spray; the spray is not sold on this platform. Mutoral® I is supplied for use within observational FCGS protocols under veterinary guidance; outcomes are tracked as observational response over the course of the protocol rather than as a guaranteed cure.